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Summary
Background COVID-19 has disproportionately affected minority ethnic populations in the UK. Our aim was to quantify 
ethnic differences in SARS-CoV-2 infection and COVID-19 outcomes during the first and second waves of the 
COVID-19 pandemic in England.
Methods We conducted an observational cohort study of adults (aged ≥18 years) registered with primary care 
practices in England for whom electronic health records were available through the OpenSAFELY platform, and 
who had at least 1 year of continuous registration at the start of each study period (Feb 1 to Aug 3, 2020 [wave 1], and 
Sept 1 to Dec 31, 2020 [wave 2]). Individual-level primary care data were linked to data from other sources on the 
outcomes of interest: SARS-CoV-2 testing and positive test results and COVID-19-related hospital admissions, 
intensive care unit (ICU) admissions, and death. The exposure was self-reported ethnicity as captured on the 
primary care record, grouped into five high-level census categories (White, South Asian, Black, other, and mixed) 
and 16 subcategories across these five categories, as well as an unknown ethnicity category. We used multivariable 
Cox regression to examine ethnic differences in the outcomes of interest. Models were adjusted for age, sex, 
deprivation, clinical factors and comorbidities, and household size, with stratification by geographical region.
Findings Of 17 288 532 adults included in the study (excluding care home residents), 10 877 978 (62·9%) were 
White, 1 025 319 (5·9%) were South Asian, 340 912 (2·0%) were Black, 170 484 (1·0%) were of mixed ethnicity, 
320 788 (1·9%) were of other ethnicity, and 4 553 051 (26·3%) were of unknown ethnicity. In wave 1, the likelihood 
of being tested for SARS-CoV-2 infection was slightly higher in the South Asian group (adjusted hazard ratio 1·08 
[95% CI 1·07–1·09]), Black group (1·08 [1·06–1·09]), and mixed ethnicity group (1·04 [1·02–1·05]) and was 
decreased in the other ethnicity group (0·77 [0·76–0·78]) relative to the White group. The risk of testing positive 
for SARS-CoV-2 infection was higher in the South Asian group (1·99 [1·94–2·04]), Black group (1·69 [1·62–1·77]), 
mixed ethnicity group (1·49 [1·39–1·59]), and other ethnicity group (1·20 [1·14–1·28]). Compared with the White 
group, the four remaining high-level ethnic groups had an increased risk of COVID-19-related hospitalisation 
(South Asian group 1·48 [1·41–1·55], Black group 1·78 [1·67–1·90], mixed ethnicity group 1·63 [1·45–1·83], other 
ethnicity group 1·54 [1·41–1·69]), COVID-19-related ICU admission (2·18 [1·92–2·48], 3·12 [2·65–3·67], 
2·96 [2·26–3·87], 3·18 [2·58–3·93]), and death (1·26 [1·15–1·37], 1·51 [1·31–1·71], 1·41 [1·11–1·81], 
1·22 [1·00–1·48]). In wave 2, the risks of hospitalisation, ICU admission, and death relative to the White group 
were increased in the South Asian group but attenuated for the Black group compared with these risks in wave 1. 
Disaggregation into 16 ethnicity groups showed important heterogeneity within the five broader categories.
Interpretation Some minority ethnic populations in England have excess risks of testing positive for SARS-CoV-2 
and of adverse COVID-19 outcomes compared with the White population, even after accounting for differences in 
sociodemographic, clinical, and household characteristics. Causes are likely to be multifactorial, and delineating 
the exact mechanisms is crucial. Tackling ethnic inequalities will require action across many fronts, including 
reducing structural inequalities, addressing barriers to equitable care, and improving uptake of testing and 
vaccination.
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Introduction
The risks of SARS-CoV-2 infection and COVID-19 disease 
have been reported to be disproportionately increased in 
minority ethnic groups compared with White groups1–4 in 
the UK and in other countries, including the USA5 and 
Brazil.6 It is hypothesised that these differences might be 
driven by factors such as living in deprived areas; working 
in high-exposure or front-line occupations; living in 
large, multigenerational households; a higher burden of 
underlying conditions; discrimination; and poor access 
to health or community services.7–10
In the UK, the collection of ethnicity data is con-
sidered essential for identifying and reducing ethnic 
inequalities.11,12 Although there is no single universally 
accepted definition of ethnicity, it serves as an important 
social construct and surrogate marker for shared 
exposures or risks for people with similar social, biological, 
and cultural characteristics.13–15
To date, many studies on COVID-19 have reported 
findings according to broad ethnic categories—such as 
White, South Asian, and Black—rather than considering 
disaggregated groupings. Furthermore, most evidence has 
been derived from populations with severe disease 
requiring hospitalisation, making it difficult to extrapolate 
findings to the general population.16–21 Finally, although 
previous studies have accounted for health status, 
socioeconomic deprivation, or household composition, 
none yet have considered these factors in conjunction.22,23
The aim of this study was to estimate the effect of 
ethnicity on being tested and testing positive for 
SARS-CoV-2, and on COVID-19-related hospitalisation, 
intensive care unit (ICU) admission, and mortality, 
recognising the potential role of sociodemographic, 
clinical, and household-related factors.
Methods
Study design and population
We did a population-based, observational cohort study 
using the OpenSAFELY platform, for which National 
Health Service (NHS) England is the data controller. 
OpenSAFELY holds electronic health record data for 
24 million people registered with primary care practices 
using TPP software, representing around 40% of the 
population of England.
Individual-level primary care data were linked to 
SARS-CoV-2 testing data from the Second Generation 
Surveillance System, COVID-19-related hospital admis-
sions from the Secondary Uses Service, COVID-19-related 
ICU admissions from the Intensive Care National Audit & 
Research Centre,24 and mortality data from the Office for 
National Statistics (ONS). The study population comprised 
adults aged 18 years and older who were registered with a 
primary care practice on Feb 1, 2020. The study periods 
were from Feb 1 to Aug 3, 2020 (for wave 1), and from 
Sept 1 to Dec 31, 2020 (for wave 2). A minimum of 
12 months of continuous registration before the start date 
Research in context
Evidence before this study
We searched PubMed for population-based studies examining 
the association between ethnicity and COVID-19. Keywords 
included (ethnic* OR race) AND (COVID OR coronavirus OR 
SARS-CoV-2) AND (UK or England) AND (risk OR rate OR odds). 
Results were filtered to human studies published from 
2019 onwards with abstracts available. We identified six studies 
examining ethnic differences in SARS-CoV-2 infection and 
COVID-19 outcomes in population-based samples. Five studies 
from the UK Biobank reported an increased risk of SARS-CoV-2 
infection and COVID-19-related hospitalisation in Black and 
South Asian groups compared with White groups. As the UK 
Biobank cohort is known to be healthier, less deprived, and less 
ethnically diverse than the UK population, these findings are 
not wholly generalisable to the wider UK population. Our 
previous study using the OpenSAFELY platform showed an 
increased risk of COVID-19-related death in minority ethnic 
groups, but did not examine the role of household size or 
examine ethnic differences in SARS-CoV-2 infection and 
COVID-19 outcomes earlier in the care pathway.
Added value of this study
This is the largest study in the UK to examine ethnic inequalities 
in testing positive for SARS-CoV-2 and in COVID-19-related 
outcomes in a cohort covering 40% of the population in England. 
Additionally, it is the only population-representative study to 
date that accounts for household size in addition to 
sociodemographic characteristics and clinical comorbidities. 
By examining ethnicity according to both high-level and detailed 
ethnic groupings, we have shown important ethnic differences in 
the risk of testing positive for SARS-CoV-2 and the risks of 
COVID-19-related hospital admission, intensive care unit 
admissions, and death. We showed that multiple factors 
contribute to ethnic inequalities in COVID-19 and the importance 
of these factors varies by ethnic group. Compared with wave 1, 
the risks of COVID-19-related hospitalisation and death in wave 2 
were increased for South Asian groups and reduced in all other 
ethnic minority groups relative to the White group.
Implications of all the available evidence
The risks of SARS-CoV-2 infection and severe COVID-19 
outcomes are disproportionately increased in minority ethnic 
groups, both in the UK and internationally. Reducing ethnic 
inequalities in COVID-19 risks requires action on social 
determinants including addressing disadvantage and 
discrimination, reducing risk of infection and transmission, 
improving quality of and access to quality clinical care, and 
improving management of pre-existing clinical conditions. 
The appropriate balance of these actions needs tailoring for 
different ethnic groups.
For the OpenSAFELY platform 
see https://opensafely.org/
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of each wave was required for inclusion, to ensure that 
baseline factors were adequately captured. Individuals 
residing in care homes were excluded from the main 
analyses because we hypothesised that the role of 
sociodemographic, clinical, and household characteristics 
would be systematically different for care home residents 
than for the general population.
This study was approved by the Health Research 
Authority (REC reference 20/LO/0651) and by the 
London School of Hygiene & Tropical Medicine’s 
Ethics Board (reference 21863). Patient data were 
pseudonymised for analysis and linkage using industry 
standard cryptographic hashing techniques, and all 
pseudonymised datasets transmitted for linkage onto 
OpenSAFELY were encrypted. Only aggregate statistical 
outputs could leave the TPP platform environment, 
following best practice for anonymisation of results 
such as statistical disclosure control for low cell counts. 
The OpenSAFELY research platform adheres to the 
data protection principles of the UK Data Protection 
Act 2018 and the EU General Data Protection 
Regulation 2016.
Exposures
The primary exposure was self-reported ethnicity as 
captured on the primary care record, collapsed into the 
five high-level and 16 detailed census categories of White 
(White British, White Irish, other White), South Asian 
(Indian, Pakistani, Bangladeshi, other South Asian), 
Black (African, Caribbean, other Black), other (Chinese, 
all others), and mixed (White and Asian, White and 
African, White and Caribbean, other mixed). An unknown 
ethnicity category was also included. Comparisons were 
reported for the five high-level ethnic groups with the 
White group as the reference category, and for the 
16 disaggregated groups, with the White British group as 
the reference category.
Outcomes
Outcomes of interest included receiving a PCR test 
for SARS-CoV-2, testing positive for SARS-CoV-2, and 
COVID-19-related hospital admission, ICU admission, 
and death (defined as the presence of ICD-10 codes U07.1 
[confirmed COVID-19] or U07.2 [suspected COVID-19] 
anywhere on the death certificate). Testing outcomes were 
obtained from the UK’s pillar 1 (NHS and Public Health 
England laboratories) and pillar 2 (commercial partners) 
testing strategies and included results from PCR swab 
tests used to identify symptomatic individuals.25,26
Covariates
Demographic characteristics included age, sex, 
deprivation, household size, number of primary care 
consultations in the past 12 months, and geographical 
region (defined by the sustainability and transfor-
mation partnership [STP], an NHS administrative area). 
Deprivation was defined using quintiles of the Index of 
Multiple Deprivation, an area-level composite measure 
of seven domains: income, employment, education, 
skills and training, health and disability, crime, and 
barriers to housing services and living environment.27 
Household size (categorised as 1–2, 3–5, 6–10, or 
≥11 people) was determined using the number of 
individuals of all ages in OpenSAFELY residing at the 
same address on Feb 1, 2020.
Clinical covariates were identified using the Read 
clinical classification system28 and included body-
mass index (BMI), glycated haemoglobin (HbA1c), 
blood pressure, and smoking status. BMI in kg/m² 
was grouped into six categories using the WHO 
classification, with adjustments for South Asian 
ethnicity: under weight (<18·5 kg/m²), normal weight 
(18·5–24·9 kg/m² [or 18·5–23·5 kg/m² if South Asian]), 
overweight (25·0–29·9 kg/m² [23·6–27·5 kg/m²]); 
obese I (30·0–34·9 kg/m² [27·5–32·4 kg/m²]); obese II 
(35·0–39·9 kg/m² [32·5–37·4 kg/m²]); and obese III 
(≥40 kg/m² [≥37·5 kg/m²]). HbA1c was grouped into 
five categories (<6·5%, 6·5–7·4%, 7·5–7·9%, 8·0–8·9%, 
and ≥9·0%). Blood pressure was grouped into four 
categories: normal (<120/<80); elevated (120 to 130/<80); 
high, stage I (131 to <140/80 to <90); and high, stage II 
(≥140/≥90). Smoking status was grouped into current, 
former, and never smokers. Those with missing 
smoking status were categorised as never smokers. 
Those with missing BMI, HbA1c, or blood pressure data 
were grouped into a separate category of “unknown”.
Clinical comorbidities were considered present at 
baseline if they were recorded at any time before 
Feb 1, 2020 (for wave 1) or Sept 1, 2020 (for wave 2). 
Comorbidities included the following: hypertension, 
asthma, chronic respiratory disease, chronic heart dis-
ease, type 1 and type 2 diabetes, cancer, chronic liver 
disease, stroke, dementia, other chronic neurological 
diseases, chronic kidney disease (defined as an estimated 
glomerular filtration rate <60 mL/min per 1·73 m²), 
end-stage renal failure, common autoimmune diseases 
(rheumatoid arthritis, systemic lupus erythematosus, 
or psoriasis), and immunosuppression (HIV infection, 
sickle cell disease, organ transplant, or asplenia). All 
codelists are available for review and reuse.29
Statistical analysis
Sociodemographic and clinical characteristics at baseline 
were summarised using descriptive statistics, stratified 
by ethnic group. Follow-up began on Feb 1, 2020, for 
wave 1 and on Sept 1, 2020, for wave 2, and ended at the 
earliest occurrence of the outcome of interest, death, 
deregistration from a primary care practice, or the 
censoring date for the dataset capturing the outcome of 
interest (from July 30 to Aug 3, 2020, [ for wave 1] or to 
Dec 31, 2020 [ for wave 2]).
Multivariable Cox proportional hazards regression was 
used to estimate ethnic differences in the cause-specific 
hazard of each outcome in the whole denominator 
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population.30 All analyses were adjusted for age (using 
restricted cubic splines), sex, deprivation quintile, 
diagnosed comorbidities, BMI, HbA1c, blood pressure, 
number of primary care consultations in the preceding 
12 months, and household size. To investigate the extent 
to which age-sex-adjusted ethnicity-associated differ ences 
could further be explained by deprivation, comorbidities, 
and household size, we sequentially adjusted for age and 
sex in the first model, adding deprivation in the second 
model, comorbidities, clinical factors, and primary care 
consultations in the third model, and household size in 
the fourth model. All models were stratified by STP to 
account for clustering by geographical region. All analyses 
were done separately for wave 1 and wave 2. Analyses of 
COVID-19-related hospital admissions for wave 1 were 
added during the revision stage of this Article as data on 
hospitalisations became available in OpenSAFELY after 
the initial submission; therefore, cohort sizes slightly 
differ for this outcome compared with other outcomes.
In secondary analyses, we estimated ethnic differences 
in the risk of non-COVID-19 death (defined as any 
death without a COVID-19 diagnosis code anywhere on 
the death certificate). Additionally, we used logistic 
regression adjusting for all covariates to examine ethnic 
differences in the odds of testing positive among those 
tested for SARS-CoV-2. We also estimated differences 
between ethnic groups in all outcomes for care home 
residents, adjusting for all covariates except for 
household size.
In sensitivity analyses, we used multiple imputation to 
account for missing ethnicity data, examining differences 
between ethnic groups in the risk of death where 
COVID-19 was the underlying cause (rather than any 
cause) and exploring the effect of regional variation on 
ethnic differences in all outcomes. Proportional hazards 
assumptions were assessed by testing for a zero slope in 
the scaled Schoenfeld residuals and graphical inspection 
of Kaplan-Meier plots.
Data management was done with Python 3.8 and SQL, 
and analysis was done using Stata 16.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report.
Results
From a total of 23 600 617 individuals in the OpenSAFELY 
database on Feb 1, 2020, 17 288 532 adults aged 18 years or 
older who met the selection criteria were included in the 
study (figure 1). The ethnic breakdown of the study 
population was 10 877 978 (62·9%) people of White 
ethnicity, 1 025 319 (5·9%) of South Asian ethnicity, 
340 912 (2·0%) of Black ethnicity, 320 788 (1·9%) of 
other ethnicity, 170 484 (1·0%) of mixed ethnicity, and 
4 553 051 (26·3%) of unknown ethnicity. Compared with 
the White population, minority ethnic groups were 
younger and over-represented in deprived neighbour-
hoods, large households, and diabetic populations 
(table 1; appendix p 3).
Between Feb 1 and Aug 3, 2020 (wave 1), 1 216 801 (7·0%) 
people in the study population received a test for 
SARS-CoV-2 infection, and 71 246 (0·4%) tested positive 
(table 2). The ethnic breakdown of individuals who 
received a test was similar to that of the general 
population, although test recipients were slightly older 
with more comorbid chronic conditions than the general 
population (appendix p 4). After accounting for all 
measured explanatory variables (age, sex, deprivation, 
comorbidities, clinical factors, primary care consultations 
in the preceding 12 months, and household size, with 
stratification by STP region), South Asian, Black, and 
mixed ethnicity groups were more likely to be tested 
(South Asian group adjusted hazard ratio [HR] 1·08 
[95% CI 1·07–1·09], Black group 1·08 [1·06–1·09], mixed 
ethnicity group 1·04 [1·02–1·05]) and to test positive 
for SARS-CoV-2 (1·99 [1·94–2·04], 1·69 [1·62–1·77], 
1·49 [1·39–1·59]) compared with the White ethnic group 
(figure 2). Across the 16 subcategories of ethnicity, risks 
of testing positive were similar to those of the respective 
high-level categories, except for the Chinese group, for 
whom risks of being tested and testing positive 
(0·49 [0·42–0·58]) were lower than for the White British 
group. When restricted to the population who had ever 
received a test (as opposed to the whole denominator 
population used in the primary analysis), patterns by 
Figure 1: Study population flowchart
23 600 617 people registered with a general practice 
using TPP software as of Feb 1, 2020 
21 750 276 with at least 1 year of follow-up before 
Feb 1, 2020
17 510 397 aged ≥18 years
17 366 656 meeting inclusion criteria
17 288 532 included in final study population
1 850 341 with <1 year of previous follow-up
4 239 879 aged <18 years on Feb 1, 2020                  
78 124 residing in care homes at the 
start of follow-up
143 741 missing sex and deprivation 
information                 
See Online for appendix
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ethnic group remained unchanged, except for the 
Chinese group, who had an equivalent risk of testing 
positive (odds ratio [OR] 1·13 [95% CI 0·95–1·34], 
adjusted for all explanatory variables; appendix p 15).
Between Feb 1 and Aug 3, 2020, 32 473 (0·2%) 
individuals in the study population were admitted to 
hospital for COVID-19, 3096 (<0·1%) were admitted to 
ICU for COVID-19, and there were 11 649 (0·1%) 
COVID-19-related deaths (table 2). After accounting for 
all measured explanatory factors, risk of hospitalisation 
was increased, relative to the White reference groups, in 
all minority ethnic groups (South Asian group adjusted 
HR 1·48 [95% CI 1·41–1·55], Black group 1·78 
[1·67–1·90], mixed ethnicity group 1·63 [1·45–1·83], 
other ethnicity group 1·54 [1·41–1·69]), including all 
minority ethnic subcategories except the Chinese group 
(0·97 [0·77–1·23]; figure 3A). Risk of ICU admission was 
around 2–3 times in the four broad minority ethnic 
groups (South Asian group 2·18 [1·92–2·48], Black group 
3·12 [2·65–3·67], mixed ethnicity group 2·96 [2·26–3·87], 
other ethnicity group 3·18 [2·58–3·93]) relative to the 
White reference group, and around 2–5 times higher 
among South Asian, Black, mixed, and other ethnic 
subcategories relative to the White British group 
(figure 3B). Risk of COVID-19-related death was 
increased by 22–51% in the four broad minority ethnic 
groups relative to the White group (South Asian group 
1·26 [1·15–1·37], Black group 1·51 [1·31–1·71], mixed 
ethnicity group 1·41 [1·11–1·81], other ethnicity group 
1·22 [1·00–1·48]; figure 4).
After accounting for age and sex, further adjustment 
had little effect on the likelihood of being tested for 
COVID-19. In South Asian groups, adjustment for 
clinical characteristics led to the largest reduction in HRs 
for testing positive for SARS-CoV-2 and hospitalisation 
and ICU admission due to COVID-19, and adjustment 
for deprivation and household size made equivalent 
reductions in HRs for COVID-19-related mortality. In all 
other minority ethnic groups, adjustment for social 
deprivation led to the largest reduction in HRs for all 
outcomes after accounting for age and sex (table 2; 
appendix p 5).
Between Sept 1 and Dec 31, 2020 (wave 2), 
2 647 756 (15·3%) individuals in the study population 
received a test for SARS-CoV-2, 506 773 (2·9%) tested 
positive, 18 885 (0·1%) were admitted to hospital for 
COVID-19, 3351 (<0·1%) had a COVID-19 related ICU 
admission, and there were 7366 (<0·1%) COVID-19-related 
deaths. In contrast to wave 1, all four of the broad minority 
ethnic groups were less likely to be tested than the White 
group, and this pattern was also seen in all minority ethnic 
subcategories relative to the White British subcategory, 
with the exception of the Pakistani group (figure 2). The 
South Asian group (and each of its subgroups) remained 
at higher risk of testing positive (adjusted HR 1·32 [95% CI 
1·31–1·33]) than the White group, and the risks of 
COVID-19-related hospitalisation (1·89 [1·79–2·00]), ICU 
admission (2·68 [2·39–3·01]), and death (1·87 [1·68–2·07]) 
were relatively greater in magnitude in wave 2 than in 
wave 1 (figures 2–4). In contrast to wave 1, the Black group 
(and all Black subgroups) was less likely than the White 
group to test positive (0·85 [0·84–0·87]; figure 2), although 
the risk of testing positive remained higher among those 















Age, years 49·6 (18·6) 51·2 (18·2) 43·0 (15·4) 43·8 (15·5) 40·0 (14·9) 40·2 (15·0) 48·8 (20·0)
Sex
Female 8 638 780 (50·0%) 5 650 496 (51·9%) 490 641 (47·9%) 169 832 (49·8%) 87 678 (51·4%) 157 832 (49·2%) 2 082 301 (45·7%)
Male 8 649 752 (50·0%) 5 227 482 (48·1%) 534 678 (52·1%) 171 080 (50·2%) 82 806 (48·6%) 162 956 (50·8%) 2 470 750 (54·3%)
Index of Multiple Deprivation
1 (most affluent) 3 495 006 (20·2%) 2 294 962 (21·1%) 87 798 (8·6%) 22 716 (6·7%) 22 259 (13·1%) 43 209 (13·5%) 1 024 062 (22·5%)
2 3 481 686 (20·1%) 2 292 018 (21·1%) 114 552 (11·2%) 34 646 (10·2%) 27 255 (16·0%) 54 638 (17·0%) 958 577 (21·1%)
3 3 487 259 (20·2%) 2 220 520 (20·4%) 189 485 (18·5%) 54 731 (16·1%) 32 256 (18·9%) 60 843 (19·0%) 929 424 (20·4%)
4 3 482 514 (20·1%) 2 113 382 (19·4%) 295 273 (28·8%) 90 963 (26·7%) 40 543 (23·8%) 79 661 (24·8%) 862 692 (18·9%)
5 (most deprived) 3 342 067 (19·3%) 1 957 096 (18·0%) 338 211 (33·0%) 137 856 (40·4%) 48 171 (28·3%) 82 437 (25·7%) 778 296 (17·1%)
Number of people in household
1–2 7 533 408 (43·6%) 5 169 700 (47·5%) 209 599 (20·4%) 118 164 (34·7%) 62 417 (36·6%) 118 594 (37·0%) 1 854 934 (40·7%)
3–5 6 166 295 (35·7%) 3 762 179 (34·6%) 430 932 (42·0%) 135 543 (39·8%) 69 564 (40·8%) 117 587 (36·7%) 1 650 490 (36·3%)
6–10 992 375 (5·7%) 443 780 (4·1%) 221 312 (21·6%) 50 678 (14·9%) 18 183 (10·7%) 39 841 (12·4%) 218 581 (4·8%)
≥11 169 045 (1·0%) 75 056 (0·7%) 41 039 (4·0%) 6486 (1·9%) 3475 (2·0%) 14 228 (4·4%) 28 761 (0·6%)
Unknown 2 427 409 (14·0%) 1 427 263 (13·1%) 122 437 (11·9%) 30 041 (8·8%) 16 845 (9·9%) 30 538 (9·5%) 800 285 (17·6%)
Number of general practitioner 
















(Table 1 continues on next page)
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(Continued from previous page)
Smoking status
Never* 8 653 213 (50·1%) 4 882 899 (44·9%) 751 034 (73·2%) 232 984 (68·3%) 96 363 (56·5%) 208 450 (65·0%) 2 481 483 (54·5%)
Former 5 683 564 (32·9%) 4 037 473 (37·1%) 159 103 (15·5%) 63 290 (18·6%) 39 798 (23·3%) 58 768 (18·3%) 1 325 132 (29·1%)
Current 2 951 755 (17·1%) 1 957 606 (18·0%) 115 182 (11·2%) 44 638 (13·1%) 34 323 (20·1%) 53 570 (16·7%) 746 436 (16·4%)
BMI, kg/m² 27·4 (5·7) 27·5 (5·7) 26·6 (5·1) 28·0 (5·7) 26·8 (5·7) 25·2 (5·1) 27·7 (5·9)
BMI category, with adjustment for South Asian populations
Underweight 294 735 (1·7%) 180 046 (1·7%) 26 124 (2·5%) 5012 (1·5%) 3800 (2·2%) 11 844 (3·7%) 67 909 (1·5%)
Normal 4 571 011 (26·4%) 3 234 076 (29·7%) 176 170 (17·2%) 81 236 (23·8%) 53 668 (31·5%) 120 216 (37·5%) 905 645 (19·9%)
Overweight 4 666 217 (27·0%) 3 218 869 (29·6%) 313 478 (30·6%) 97 270 (28·5%) 42 901 (25·2%) 71 463 (22·3%) 922 236 (20·3%)
Obese I 2 457 922 (14·2%) 1 633 030 (15·0%) 212 808 (20·8%) 54 909 (16·1%) 20 662 (12·1%) 27 228 (8·5%) 509 285 (11·2%)
Obese II 949 367 (5·5%) 631 273 (5·8%) 71 428 (7·0%) 21 383 (6·3%) 7825 (4·6%) 8355 (2·6%) 209 103 (4·6%)
Obese III 474 090 (2·7%) 318 199 (2·9%) 28 812 (2·8%) 10 282 (3·0%) 4076 (2·4%) 3505 (1·1%) 109 216 (2·4%)
Unknown 3 875 190 (22·4%) 1 662 485 (15·3%) 196 499 (19·2%) 70 820 (20·8%) 37 552 (22·0%) 78 177 (24·4%) 1 829 657 (40·2%)
HbA1c, % 5·9 (1·0) 5·8 (1·0) 6·1 (1·2) 6·0 (1·2) 5·9 (1·1) 5·8 (1·0) 5·9 (1·0)
HbA1c, mmol/mol 41·0 (92·7) 40·4 (62·2) 44·3 (218·2) 42·8 (138·9) 40·5 (12·0) 40·2 (10·7) 41·4 (101·9)
HbA1c category
<6·5% 6 706 373 (38·8%) 4 546 662 (41·8%) 424 221 (41·4%) 127 134 (37·3%) 54 728 (32·1%) 92 552 (28·9%) 1 461 076 (32·1%)
6·5–7·4% 582 059 (3·4%) 350 237 (3·2%) 64 385 (6·3%) 15 294 (4·5%) 4500 (2·6%) 7680 (2·4%) 139 963 (3·1%)
7·5–7·9% 155 580 (0·9%) 94 158 (0·9%) 17 117 (1·7%) 3376 (1·0%) 1144 (0·7%) 1825 (0·6%) 37 960 (0·8%)
8·0–8·9% 168 963 (1·0%) 103 062 (0·9%) 18 312 (1·8%) 3558 (1·0%) 1226 (0·7%) 1965 (0·6%) 40 840 (0·9%)
≥9·0% 190 305 (1·1%) 115 910 (1·1%) 21 060 (2·1%) 5415 (1·6%) 1686 (1·0%) 2215 (0·7%) 44 019 (1·0%)
Unknown 9 485 252 (54·9%) 5 667 949 (52·1%) 480 224 (46·8%) 186 135 (54·6%) 107 200 (62·9%) 214 551 (66·9%) 2 829 193 (62·1%)
Blood pressure (mm Hg)
Systolic 128·0 (15·7) 128·3 (15·5) 123·8 (15·4) 127·1 (16·0) 124·0 (15·3) 122·5 (15·4) 129·0 (15·9)
Diastolic 76·8 (9·9) 76·8 (9·8) 76·5 (9·7) 78·0 (10·3) 76·6 (10·1) 75·8 (10·0) 76·7 (10·0)
Blood pressure category
Normal 2 653 823 (15·4%) 1 719 408 (15·8%) 211 095 (20·6%) 56 786 (16·7%) 32 711 (19·2%) 57 475 (17·9%) 576 348 (12·7%)
Elevated 1 818 544 (10·5%) 1 225 760 (11·3%) 99 291 (9·7%) 32 093 (9·4%) 15 713 (9·2%) 23 598 (7·4%) 422 089 (9·3%)
High, stage I 4 270 604 (24·7%) 2 880 135 (26·5%) 238 962 (23·3%) 80 605 (23·6%) 35 154 (20·6%) 53 458 (16·7%) 982 290 (21·6%)
High, stage II 3 010 178 (17·4%) 2 025 395 (18·6%) 120 401 (11·7%) 54 017 (15·8%) 19 008 (11·1%) 26 433 (8·2%) 764 924 (16·8%)
Unknown 5 535 383 (32·0%) 3 027 280 (27·8%) 355 570 (34·7%) 117 411 (34·4%) 67 898 (39·8%) 159 824 (49·8%) 1 807 400 (39·7%)
Comorbidities
Type 1 diabetes 88 294 (0·5%) 59 940 (0·6%) 2508 (0·2%) 1363 (0·4%) 637 (0·4%) 637 (0·2%) 23 209 (0·5%)
Type 2 diabetes 1 234 858 (7·1%) 747 798 (6·9%) 135 741 (13·2%) 31 590 (9·3%) 9603 (5·6%) 15 527 (4·8%) 294 599 (6·5%)
Diagnosed hypertension 3 703 816 (21·4%) 2 437 571 (22·4%) 173 237 (16·9%) 69 524 (20·4%) 20 712 (12·1%) 31 706 (9·9%) 971 066 (21·3%)
Chronic heart disease 1 193 155 (6·9%) 803 572 (7·4%) 53 903 (5·3%) 11 092 (3·3%) 4731 (2·8%) 8136 (2·5%) 311 721 (6·8%)
Stroke 368 707 (2·1%) 249 742 (2·3%) 12 429 (1·2%) 4373 (1·3%) 1495 (0·9%) 2161 (0·7%) 98 507 (2·2%)
Chronic kidney disease† 978 300 (5·7%) 647 085 (5·9%) 27 979 (2·7%) 15 042 (4·4%) 3787 (2·2%) 4782 (1·5%) 279 625 (6·1%)
End-stage renal failure 25 348 (0·1%) 14 615 (0·1%) 2410 (0·2%) 878 (0·3%) 219 (0·1%) 352 (0·1%) 6874 (0·2%)
Cancer 979 433 (5·7%) 684 824 (6·3%) 19 868 (1·9%) 9249 (2·7%) 3718 (2·2%) 6640 (2·1%) 255 134 (5·6%)
Autoimmune disease 889 832 (5·1%) 615 132 (5·7%) 37 348 (3·6%) 6912 (2·0%) 4988 (2·9%) 7504 (2·3%) 217 948 (4·8%)
Immunosuppression 93 162 (0·5%) 54 143 (0·5%) 4602 (0·4%) 10 087 (3·0%) 2118 (1·2%) 1425 (0·4%) 20 787 (0·5%)
Chronic liver disease 104 781 (0·6%) 69 901 (0·6%) 5677 (0·6%) 3035 (0·9%) 894 (0·5%) 2445 (0·8%) 22 829 (0·5%)
Dementia 34 169 (0·2%) 22 855 (0·2%) 1199 (0·1%) 538 (0·2%) 106 (0·1%) 195 (0·1%) 9276 (0·2%)
Neurological disease 169 483 (1·0%) 116 300 (1·1%) 5803 (0·6%) 1951 (0·6%) 888 (0·5%) 1163 (0·4%) 43 378 (1·0%)
Asthma 2 663 321 (15·4%) 1 790 975 (16·5%) 125 745 (12·3%) 37 351 (11·0%) 25 776 (15·1%) 22 406 (7·0%) 661 068 (14·5%)
Chronic respiratory disease 718 047 (4·2%) 527 265 (4·8%) 17 435 (1·7%) 5003 (1·5%) 2274 (1·3%) 3520 (1·1%) 162 550 (3·6%)
Data are mean (SD), n (%), or median (IQR). BMI=body-mass index. HbA1c=glycated haemoglobin. *Including those with missing data. †Defined as estimated glomerular filtration rate <60 mL/min per 1·73 m².
Table 1: Baseline characteristics by ethnic group
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explanatory variables; appendix p 15), rather than the 
general denominator population. Risks of COVID-19-
related hospitalisation (adjusted HR 1·23 [95% CI 
1·11–1·37]) and ICU admission (1·67 [1·37–2·05]) 
remained higher for the Black group than for the White 
group in wave 2, but these risks were attenuated in 
magnitude compared with wave 1 (figure 3). However, in 
contrast to the pattern seen in the broader Black group, the 
risk of COVID-19-related hospitalisation in the Caribbean 
subgroup did not differ from that of the White British 
group (0·98 [0·81–1·17]). Additionally, the excess risk of 
COVID-19 death was attenuated for the Black group in 
wave 2 compared with wave 1, so that no differences 
between the White and Black groups remained in wave 2 
(0·92 [0·73–1·16]; figure 4).
71 920 non-COVID-19-related deaths occurred in the 
study population during wave 1. The risk of non-COVID-19-
related death was 15–32% lower in all non-White ethnic 
groups (South Asian group adjusted HR 0·85 [95% CI 
0·81–0·90], Black group 0·85 [0·78–0·92], mixed ethnicity 
Denominator Events Hazard ratio (95% CI)




Tested for SARS-CoV-2 (n=1 216 801)
White 10 877 978 793 181 (7·3%) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
South Asian 1 025 319 82 647 (8·1%) 1·08 (1·08–1·09) 1·11 (1·10–1·12) 1·09 (1·08–1·09) 1·09 (1·08–1·09) 1·08 (1·07–1·09)
Black 340 912 25 305 (7·4%) 1·04 (1·03–1·05) 1·08 (1·06–1·09) 1·04 (1·03–1·06) 1·08 (1·06–1·09) 1·08 (1·06–1·09)
Mixed 170 484 12 126 (7·1%) 1·00 (0·98–1·01) 1·03 (1·01–1·05) 1·01 (1·00–1·03) 1·04 (1·02–1·06) 1·04 (1·02–1·05)
Other 320 788 15 824 (4·9%) 0·68 (0·67–0·69) 0·71 (0·69–0·72) 0·70 (0·69–0·71) 0·78 (0·77–0·79) 0·77 (0·76–0·78)
Unknown 4 553 051 287 718 (6·3%) 0·86 (0·86–0·87) 0·88 (0·88–0·89) 0·89 (0·88–0·89) 0·97 (0·97–0·98) 0·97 (0·97–0·98)
Tested positive for SARS-CoV-2 (n=71 246)
White 10 877 978 41 180 (0·4%) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
South Asian 1 025 319 9679 (0·9%) 2·38 (2·32–2·43) 2·64 (2·57–2·70) 2·45 (2·39–2·51) 2·16 (2·10–2·21) 1·99 (1·94–2·04)
Black 340 912 2286 (0·7%) 1·82 (1·74–1·90) 2·04 (1·95–2·13) 1·86 (1·78–1·94) 1·74 (1·67–1·82) 1·69 (1·62–1·77)
Mixed 170 484 840 (0·5%) 1·37 (1·28–1·46) 1·59 (1·48–1·70) 1·52 (1·42–1·63) 1·51 (1·41–1·62) 1·49 (1·39–1·59)
Other 320 788 1213 (0·4%) 1·06 (1·00–1·12) 1·22 (1·15–1·29) 1·18 (1·11–1·25) 1·25 (1·18–1·33) 1·20 (1·14–1·28)
Unknown 4 553 051 16 048 (0·4%) 0·97 (0·95–0·99) 0·99 (0·98–1·01) 1·00 (0·98–1·02) 1·06 (1·04–1·08) 1·06 (1·04–1·08)
COVID-19-related hospital admission† (n=32 473)
White 11 110 312 20 504 (0·2%) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
South Asian 1 026 551 2836 (0·3%) 1·26 (1·21–1·31) 2·04 (1·96–2·13) 1·83 (1·76–1·91) 1·59 (1·52–1·66) 1·48 (1·41–1·55)
Black 342 561 1051 (0·3%) 1·39 (1·30–1·48) 2·18 (2·05–2·33) 1·89 (1·77–2·01) 1·81 (1·70–1·94) 1·78 (1·67–1·90)
Mixed 171 933 302 (0·2%) 0·86 (0·77–0·97) 1·78 (1·59–1·99) 1·64 (1·47–1·84) 1·65 (1·47–1·85) 1·63 (1·45–1·83)
Other 323 529 504 (0·2%) 0·77 (0·71–0·85) 1·52 (1·39–1·66) 1·43 (1·31–1·57) 1·59 (1·45–1·74) 1·54 (1·41–1·69)
Unknown 4 408 386 7276 (0·2%) 0·91 (0·88–0·93) 0·96 (0·94–0·99) 0·97 (0·94–0·99) 1·06 (1·03–1·09) 1·06 (1·03–1·09)
COVID-19-related intensive care unit admission (n=3096)
White‡ 10 877 978 1700 (<0·1%) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
South Asian 1 025 319 410 (<0·1%) 2·38 (2·12–2·67) 3·30 (2·93–3·71) 3·05 (2·71–3·44) 2·34 (2·07–2·64) 2·18 (1·92–2·48)
Black 340 912 186 (0·1%) 3·08 (2·63–3·60) 3·91 (3·34–4·58) 3·52 (3·00–4·13) 3·21 (2·73–3·77) 3·12 (2·65–3·67)
Mixed 170 484 56 (<0·1%) 1·97 (1·51–2·57) 3·19 (2·44–4·17) 3·01 (2·30–3·94) 3·02 (2·31–3·95) 2·96 (2·26–3·87)
Other 320 788 97 (<0·1%) 1·83 (1·48–2·25) 2·92 (2·37–3·60) 2·80 (2·27–3·45) 3·28 (2·66–4·06) 3·18 (2·58–3·93)
Unknown 4 553 051 662 (<0·1%) 0·95 (0·87–1·04) 1·03 (0·94–1·12) 1·03 (0·94–1·13) 1·09 (0·99–1·19) 1·08 (0·99–1·19)
COVID-19-related death (n=11 649)
White 10 877 978 7514 (0·1%) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
South Asian 1 025 319 734 (0·1%) 0·89 (0·83–0·97) 1·85 (1·71–2·01) 1·64 (1·52–1·78) 1·47 (1·35–1·60) 1·26 (1·15–1·37)
Black 340 912 268 (0·1%) 0·96 (0·85–1·09) 1·88 (1·66–2·13) 1·61 (1·42–1·82) 1·50 (1·32–1·70) 1·51 (1·33–1·71)
Mixed 170 484 65 (<0·1%) 0·51 (0·40–0·65) 1·58 (1·23–2·01) 1·44 (1·13–1·84) 1·43 (1·12–1·83) 1·41 (1·11–1·81)
Other 320 788 107 (<0·1%) 0·44 (0·37–0·54) 1·25 (1·03–1·51) 1·17 (0·97–1·42) 1·24 (1·02–1·50) 1·22 (1·00–1·48)
Unknown 4 553 051 2961 (0·1%) 0·95 (0·91–0·99) 0·92 (0·88–0·96) 0·93 (0·89–0·97) 1·00 (0·95–1·04) 1·01 (0·97–1·06)
Data are N, n (%), or hazard ratio (95% CI). *Including number of primary care consultations in the preceding 12 months. †Analyses of COVID-19-related hospital admissions 
for wave 1 were added during the revision stage of this Article as data on hospitalisations became available in OpenSAFELY after the initial submission; therefore, cohort sizes 
differ for this outcome compared with other outcomes. ‡For categories containing small numbers (≤5) within any subcategory, we have rounded all counts to the nearest 10, 
per data disclosure agreements. 
Table 2: Associations between ethnicity in five categories and COVID-19 outcomes in wave 1, with serial adjustment
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group 0·81 [0·70–0·93]; other ethnicity group 0·68 
[0·61–0·77]) than in the White group after adjustment for 
all measured explanatory variables (appendix p 5). In 
wave 2, the risk of non-COVID-19-related death remained 
lower for the South Asian, Black, and other ethnicity 
groups than for the White group (appendix p 10).
Figure 2: Ethnic differences in the risks of being tested for SARS-CoV-2 infection (A) and testing positive for SARS-CoV-2 infection (B)
Models adjust for age, sex, deprivation quintile, all prespecified clinical comorbidities, body-mass index category, glycated haemoglobin category, systolic and diastolic blood pressure category, number 
of primary care consultations in the previous 12 months, household size, and stratification by sustainability and transformation partnership region. HR=hazard ratio. *All White ethnicities is the reference 
category for comparison of ethnicity in the five broad categories, and White British is the reference category for comparison of ethnicity in the 16 subcategories. 
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Figure 3: Ethnic differences in the risk of COVID-19-related hospital admission (A) and COVID-19-related ICU admission (B)
Models adjust for age, sex, deprivation quintile, all prespecified clinical comorbidities, body-mass index category, glycated haemoglobin category, systolic and diastolic blood pressure category, number 
of primary care consultations in the previous 12 months, household size, and stratification by sustainability and transformation partnership region. Analyses of COVID-19-related hospital admissions 
for wave 1 were added during the revision stage of this Article as data on hospitalisations became available in OpenSAFELY after the initial submission; therefore, cohort sizes differ for this outcome 
compared with other outcomes. HR=hazard ratio. ICU=intensive care unit. *All White ethnicities is the reference category for comparison of ethnicity in the five broad categories, and White British is 
the reference category for comparison of ethnicity in the 16 subcategories. †For categories containing small numbers (≤5) within any subcategory, we have rounded all counts to the nearest 10, 
per data disclosure agreements.
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In wave 1, among the 78 124 care home residents, 
46 065 (59·0%) individuals were tested for SARS-CoV-2, 
6330 (8·1%) tested positive, 2517 (3·2%) were admitted 
to hospital, and 3877 (5·0%) died from COVID-19. 
Although no ethnic differences in being tested for or 
testing positive for SARS-CoV-2 infection were apparent, 
people of Black ethnicity (adjusted HR 1·43 [95% CI 
1·02–2·00]) and other ethnicity (1·73 [1·19–2·50]) were 
more likely to die from COVID-19 than people of White 
ethnicity, after adjustment for all measured explanatory 
variables except household size. In wave 2, no ethnic 
differences among care home populations were evident 
for any outcome except COVID-19 death, which was 
raised for South Asian groups (1·81 [1·07–3·05]; 
appendix p 16). Because of small numbers, we were 
unable to explore ethnic differences in ICU admissions 
or differences according to ethnicity in 16 categories 
among care home residents.
Using multiple imputation to account for unknown 
ethnicity did not materially change any of the associations 
observed in the complete case analysis (appendix p 17), 
nor did restricting the definition of COVID-19-related 
death to underlying cause only (appendix p 18) or 
removing adjustment for STP region (appendix p 19). We 
detected no evidence of deviations from the proportional 
hazards assumption (appendix p 20).
Discussion
In a population-based cohort study of 17 million adults 
in England we found that, although ethnic differences in 
testing were small, minority ethnic groups were at 
increased risk of testing positive for SARS-CoV-2 and of 
COVID-19-related hospitalisation, ICU admission, and 
death. Disaggregation into detailed ethnic categories 
revealed important within-group heterogeneity, empha-
si sing the importance of disaggregated reporting 
wherever possible. In wave 2, minority ethnic groups 
were less likely to be tested than White groups, and risks 
of severe COVID-19 outcomes (ie, hospitalisation, ICU 
admission, and death) increased for South Asian groups 
but were attenuated in all other ethnic groups relative to 
the White group compared with wave 1.
In the largest UK-based study to date, we captured 
high-quality clinical data across a range of health-care 
settings and linked individual-level COVID-19 datasets, 
which enabled us to generate timely insights into ethnic 
disparities at different severity levels of COVID-19, from 
being tested for infection to dying from the disease. We 
were able to report findings according to self-reported 
ethnicity in 16 categories, whereas other UK-based 
studies have aggregated ethnicity into higher-level groups 
because of small numbers. We also reported differences 
in outcomes using a general population-based sample, 
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Figure 4: Ethnic differences in the risk of COVID-19-related death
Models adjust for age, sex, deprivation quintile, all prespecified clinical comorbidities, body-mass index category, glycated haemoglobin category, systolic and diastolic blood pressure category, number 
of primary care consultations in the previous 12 months, household size, and stratification by sustainability and transformation partnership region. For categories containing small numbers (≤5) within 
any subcategory, we have rounded all counts to the nearest 10, per data disclosure agreements. HR=hazard ratio. *All White ethnicities is the reference category for comparison of ethnicity in the 
five broad categories, and White British is the reference category for comparison of ethnicity in the 16 subcategories.
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which allowed us to overcome issues commonly faced by 
studies limited to individuals with SARS-CoV-2 infection 
or hospitalisation, wherein the populations under study 
might not represent the true general population at risk.31
Our inability to capture all potential explanatory factors 
of ethnic disparities in COVID-19 outcomes is likely to 
have affected our observed associations. For example, we 
were unable to account for ethnic differences in genetic 
ances try,32,33 occupation,34 experiences of racism or struc-
tural discrimination,9,35,36 and health-related behaviour.37,38 
Because of invalid address information, we were unable to 
estimate household size for 13% of our population. We 
might have underestimated household size for homes 
including people registered at non-TPP primary care 
practices and overestimated it for individuals living in 
large apartment blocks, or for people who had not updated 
their address after moving homes. In recognition of these 
limitations, we grouped household size into four levels 
rather than considering it as a continuous measure. 
Furthermore, it is possible that cause of death might have 
been misclassified on death certificates, and that the extent 
of this misclassification might have differed by time period 
and ethnicity. A limitation of SARS-CoV-2 testing data was 
the selective opportunity to be tested early in the pandemic, 
which was skewed towards health-care workers and people 
with severe or symptomatic disease, particularly during 
the first wave. Although OpenSAFELY is broadly 
representative of the English population, it includes data 
from a single software system that is known to have lower 
coverage in London than in other regions of the UK. 
However, our results mirror other studies done in the UK1 
and in the USA,5,39 suggesting that potential mechanisms 
underpinning ethnic differences in COVID-19 might 
be common across countries with similar population 
structures. OpenSAFELY data are collected prospectively 
in real time by clinicians and practice staff, and are subject 
to the same strengths and biases as other UK-based 
electronic health record databases.
Despite these limitations, this study represents the 
most comprehensive examination of ethnic inequalities 
in England during the COVID-19 pandemic in 2020. 
Using the OpenSAFELY data analytics platform, we 
capitalised on the rapid real-time linkage of routine 
datasets in a highly secure environment to explore a 
range of urgent questions around the patterning of 
ethnic inequalities in the UK.
This study builds on previous research in several ways. 
First, we have confirmed ethnic differences in COVID-19-
related mortality and provided novel data across a range 
of other outcomes (testing, hospitalisation, and ICU 
admission). Second, we have explored whether household 
size has an effect beyond sociodemographic and clinical 
characteristics. Finally, we have reported on both the 
general population and care home residents during the 
first and second waves of the pandemic in England.
Although some minority ethnic groups were less likely 
to be tested for SARS-CoV-2 in this study, all non-White 
groups were more likely to test positive, even when 
restricted to those ever tested. This finding might suggest 
that White populations are tested more frequently with 
mild or asymptomatic disease, or that minority ethnic 
groups get tested at more severe stages of the disease. 
Disparities in testing might relate to a lack of access to 
testing sites, poorer health literacy, lack of tailored and 
accessible health communications, or differences in 
testing-related behaviours.40 Emerging evidence suggests 
that individuals might avoid seeking a test for fear of 
losing income or employment if required to quarantine 
after testing positive.41 Given that minority ethnic groups 
are more likely to work in insecure jobs with poor 
workplace protections, and in essential or key-worker 
roles associated with higher risk of death from 
COVID-19,42–44 it is likely that social and economic barriers 
to testing are greater in minority ethnic groups.
Our finding that minority ethnic groups have higher 
risks of COVID-19-related hospitalisation, ICU admission, 
and death after accounting for clinical comorbidities 
suggests that improving equity in clinical care and 
understanding potential interactions between COVID-19 
and underlying conditions are essential for mitigating 
inequalities in the downstream effects of SARS-CoV-2 
infection. The fact that inequalities worsened for South 
Asian groups in wave 2 compared with in wave 1 suggests 
that more aggressive and tailored interventions are needed 
to meet the needs in these communities.45 However, our 
finding of relatively attenuated risks in all other minority 
ethnic groups is a potential positive finding; further 
investigation is warranted into which public health actions 
were most influential in mitigating health disparities for 
these groups.
Our finding that the magnitude of ethnic differences in 
testing positive in wave 1 were similar to those in 
COVID-19-related death suggests that ethnic differences in 
death might be mediated through exposure or susceptibility 
to infection, rather than through susceptibility to severe 
disease once infected. This hypothesis is supported by 
recent findings from the REACT-2 study, which found 
higher levels of SARS-CoV-2 antibodies in minority ethnic 
groups but no ethnic differences in the infection-to-
mortality ratio.46
After accounting for sociodemographic and clinical 
factors, household size further explained differences in 
COVID-19 outcomes for South Asian groups. This 
finding is consistent with an ONS study that found that 
multigenerational living was causally associated with an 
increased risk of death due to COVID-19 in South Asian 
women, but not in any other ethnic groups.47 According 
to data from the 2011 census, 21% of South Asian groups 
live in multigenerational households, in contrast to 
around 7% of White groups.24,48 We hypothesise that 
household size and deprivation might proxy viral 
exposure by capturing aspects of occupational and 
community-level exposure. Although multigenerational 
living might increase the risks of exposure and 
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transmission (from children or working-age adults to 
older or vulnerable family members), such households 
and extended communities also offer valuable informal 
care networks and facilitate engagement with health and 
community services.49 In light of emerging evidence that 
minority ethnic groups are less likely to take up the 
COVID-19 vaccine, co-designing culturally competent 
and non-stigmatising engagement strategies with these 
communities is increasingly important.50,51
National data from England and Scotland have shown 
that some minority ethnic groups have both better overall 
health and lower all-cause mortality than White 
groups.52,53 We were able to confirm this pattern in our 
sensitivity analyses, and our findings of disparities in 
SARS-CoV-2 positivity and COVID-19-related outcomes, 
some of which have continued to widen over the course 
of the epidemic in the UK, are, therefore, particularly 
concerning.
Our findings mirror large studies in the USA, which 
have found that minority racial and ethnic communities 
have elevated risks of testing positive for SARS-CoV-2 
infection and of COVID-19-related hospitalisation and 
death that differentially vary over time, even after 
accounting for sociodemographic characteristics and 
underlying health conditions.5,39 These parallel findings 
suggest that mechanisms underpinning ethnic dif-
ferences in COVID-19 outcomes in England might be 
common in other settings, and that learnings across 
settings should be shared.
Improving the quality and completeness of ethnicity 
data across health and administrative datasets is essential 
for building a complete picture of ethnic disparities.54 
Furthermore, although the recording of ethnicity on 
death certificates has been the norm in Scotland for the 
past decade, it is only now being considered for use in 
England.55–57 Prioritising linkage between health, social, 
and employment data will be essential in building a 
complete picture of ethnic differences in COVID-19 risk 
and outcomes.
Minority ethnic groups in the UK have had dispro-
portionately high levels of poor COVID-19 outcomes, 
with disparities increasing even within the course of the 
epidemic for some groups. Reducing ethnic inequalities 
will need action across a broad range of measures such as 
addressing the wider adverse effects of disadvantage and 
structural discrimination, reducing within-household 
and between-household transmission, and improving 
control of clinical conditions. The relative importance of 
each of these measures will differ by both ethnic group 
and stage of COVID-19 progression. Equality is difficult 
to achieve, but structural and persistent inequalities must 
be addressed in a civilised society.
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